Malignant mixed müllerian tumor of primary mesenteric origin associated with a synchronous ovarian cancer: case report and literature review

Malignant mixed mullerian tumor (MMMT) is a rare tumor in females and extragenital MMMT is even more so. We report a patient with MMMT primarily in the mesentery with synchronous ovarian cancer. In the English literature, 42 cases of extragenital MMMT have been reported other than the presented case, and this is only the second MMMT arising from the mesentery. Furthermore, among the cases reviewed, MMMTs tend to be associated with synchronous or metachronous colonic cancer or gynecologic tumors originating from the mullerian duct, including ovarian tumors, fallopian tube cancer, endometrial cancer, cervical cancer, and serous carcinoma of the peritoneum (14 Out of 43 patients; 32.6%). The risk factors for MMMT include obesity, nulliparity, exogenous estrogen, and long-term tamoxifen use. The prognosis of MMMT is catastrophic and the treatment is based oil the experience of those of uterine sarcomas, which is composed of operation, radiotherapy and chemotherapy.

Malignant mixed müllerian tumor; Mesentery; Ovarian cancer

[1] Ober W.B., Black M.B.: “Neoplasms of the subcoelomic mesenchyme; report of two cases”. AMA Arch Pathol., 1955, 59, 698.

[2] Ferrie R.K., Ross R.C.: “Retroperitoneal Mullerian carcinosarcoma”. Can. Med. Assoc. J., 1967, 97, 1290.

[3] Weisz-Carrington P., Bigelow B., Schinella R.A.: “Extragenital mixed heterologous tumor of Mullerian type arising in the cecal peritoneum: report of a case”. Dis. Colon Rectum, 1977, 20, 329.

[4] Marchevsky A., Jacobs A.J., Deppe G., Cohen C.J.: “Extragenital homologous mixed mullerian tumor”. J. Reprod. Med., 1982, 27, 110.

[5] Herman C.W., Tessler A.N.: “Extragenital mixed heterologous tumor of mullerian type arising in retroperitoneum”. Urology, 1983, 22, 49.

[6] Hasiuk A.S., Petersen R.O., Hanjani P., Griffin T.D.: “Extragenital malignant mixed Mullerian tumor. Case report and review of the literature”. Am. J. Clin. Pathol., 1984, 81, 102.

[7] Campins M., Madrenas J., Biosca M., Salas A., Tallada N., Garcia- Bragado F.: “Extra-uterine mullerian carcinosarcoma”. Acta Obstet. Gynecol. Scand., 1986, 65, 811.

[8] Chumas J.C., Thanning L., Mann W.J.: “Malignant mixed mullerian tumor arising in extragenital endometriosis: report of a case and review of the literature”. Gynecol. Oncol., 1986, 23, 227.

[9] Nguyen G.K., Berendt R.C.: “Aspiration biopsy cytology of metastatic endometrial stromal sarcoma and extragenital mixed mesodermal tumor”. Diagn. Cytopathol., 1986, 2, 256.

[10] Chen K.T., Wolk R.W.: “Extragenital malignant mixed mullerian tumor”. Gynecol. Oncol., 1988, 30, 422.

[11] el-Jabbour J.N., Helm C.W., McLaren K.M., Smart G.E., Aitken J.: “Synchronous colonic adenocarcinoma and extragenital malignant mixed mesodermal tumour”. Scott. Med. J., 1989, 34, 567.

[12] Ohno S., Kuwano H., Mori M., Sakata H., Mori A., Shinohara K.: “Malignant mixed mesodermal tumour of the peritoneum with a complete response to cyclophosphamide”. Eur. J. Surg. Oncol., 1989, 15, 287.

[13] Garde J.R., Jones M.A., McAfee R., Tarraza H.M.: “Extragenital malignant mixed mullerian tumor: review of the literature”. Gynecol. Oncol., 1991, 43, 186.

[14] Solis O.G., Bui H.X., Malfetano J.H., Ross J.S.: “Extragenital primary mixed malignant mesodermal tumor”. Gynecol. Oncol., 1991, 43, 182.

[15] Nimaroff M., Gal D., Susin M., Lovecchio J.: “Extragenital malignant mixed mullerian tumor”. Eur. J. Gynaecol. Oncol., 1993, 14, 23.

[16] Choong S.Y., Scurry J.P., Planner R.S., Grant P.T.: “Extrauterine malignant mixed mullerian tumor of primary peritoneal origin”. Pathology, 1994, 26, 497.

[17] Garamvoelgyi E., Guillou L., Gebhard S., Salmeron M., Seematter R.J., Hadji M.H.: “Primary malignant mixed Mullerian tumor (metaplastic carcinoma) of the female peritoneum. A clinical, pathologic, and immunohistochemical study of three cases and a review of the literature”. Cancer, 1994, 74, 854.

[18] Westra W.H., Anderson B.O., Klimstra D.S.: “Carcinosarcoma of the spleen. An extragenital malignant mixed mullerian tumor?” Am. J. Surg. Pathol., 1994, 18, 309.

[19] Mira J.L., Fenoglio-Preiser C.M., Husseinzadeh N.: “Malignant mixed mullerian tumor of the extraovarian secondary mullerian system. Report of two cases and review of the English literature”. Arch. Pathol. Lab. Med., 1995, 119, 1044.

[20] Rose P.G., Rodriguez M., Abdul-Karim F.W.: “Malignant mixed mullerian tumor of the female peritoneum: treatment and outcome of three cases”. Gynecol. Oncol., 1997, 65, 523.

[21] Ibanez-Manlapaz I.G., Coy D.M., Vincent V., 3rd, Ule U.J.: “Malignant mixed mullerian tumor of the extra-genital coelomic epithelium: Report of two cases”. Pathol. Oncol. Res., 1997, 3, 130.

[22] Arai Y., Oka K., Hakozaki H., Koyamatsu S., Tobita T., Okane M., et al.: “Pelvic malignant mixed mesodermal tumor of uncertain origin: a case report”. Eur. J. Obstet. Gynecol. Reprod. Biol., 1999, 83, 227.

[23] Shen D.H., Khoo U.S., Xue W.C., Ngan H.Y., Wang J.L., Liu V.W., et al.: “Primary peritoneal malignant mixed Mullerian tumors. A clinicopathologic, immunohistochemical, and genetic study”. Cancer, 2001, 91, 1052.

[24] Shintaku M., Matsumoto T.: “Primary mullerian carcinosarcoma of the retroperitoneum: report of a case”. Int. J. Gynecol. Pathol., 2001, 20, 191.

[25] Wei L., Wang J., Zhang X., Cui H., Shen D., Qian H.: “Primary omental malignant mixed mullerian tumor in a 67-year-old woman”. Chin. Med. J. (Engl), 2002, 115, 138.

[26] Sumathi V.P., Murnaghan M., Dobbs S.P., McCluggage W.G.: “Extragenital mullerian carcinosarcoma arising from the peritoneum: report of two cases”. Int. J. Gynecol. Cancer, 2002, 12, 764.

[27] Dincer A.D., Timmins P., Pietrocola D., Fisher H., Ambros R.A.: “Primary peritoneal mullerian adenosarcoma with sarcomatous overgrowth associated with endometriosis: a case report”. Int. J. Gynecol. Pathol., 2002, 21, 65.

[28] Booth C., Zahn C.M., McBroom J., Maxwell G.L.: “Retroperitoneal mullerian carcinosarcoma associated with endometriosis: a case report”. Gynecol. Oncol., 2004, 93, 546.

[29] Ko M.L., Jeng C.J., Huang S.H., Shen J., Tzeng C.R., Chen S.C.: “Primary peritoneal carcinosarcoma (malignant mixed mullerian tumor): Report of a case with five-year disease free survival after surgery and chemoradiation and a review of literature”. Acta Oncol., 2005, 44, 756.

[30] Mikami M., Kuwabara Y., Tanaka K., Komiyama S., Ishikawa M., Hirose T.: “Malignant mixed mullerian tumor of primary mesenteric origin”. Int. J. Gynecol. Cancer, 2005, 15, 1249.

[31] Shaco-Levy R., Sion-Vardy N., Piura B.: “Primary peritoneal malignant mixed mullerian tumor associated with colonic adenocarcinoma”. Eur. J. Gynaecol. Oncol., 2005, 26, 509.

[32] Zelmanowicz A., Hildesheim A., Sherman M.E., Sturgeon S.R., Kurman R.J., Barrett R.J. et al.: “Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors”. Gynecol. Oncol., 1998, 69, 253.

[33] Curtis R.E., Freedman D.M., Sherman M.E., Fraumeni J.F., Jr.: “Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer”. J. Natl. Cancer Inst., 2004, 96, 70.

[34] McCluggage W.G., Abdulkader M., Price J.H., Kelehan P., Hamilton S., Beattie J. et al.: “Uterine carcinosarcomas in patients receiving tamoxifen. A report of 19 cases”. Int. J. Gynecol. Cancer, 2000, 10, 280.

[35] Kloos I., Delaloge S., Pautier P., Di Palma M., Goupil A., Duvillard P. et al.: “Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: report of five cases and review of the literature”. Int. J. Gynecol. Cancer, 2002, 12, 496.

[36] Wysowski D.K., Honig S.F., Beitz J.: “Uterine sarcoma associated with tamoxifen use”. N. Engl. J. Med., 2002, 346, 1832.

[37] Huang Y.T., Huang K.G., Ueng S.H., Shaw S.W.: “Irradiationinduced uterine malignant mixed mullerian tumor”. Taiwan J. Obstet. Gynecol., 2006, 45, 353.

[38] Callister M., Ramondetta L.M., Jhingran A., Burke T.W., Eifel P.J.: “Malignant mixed Mullerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome”. Int. J. Radiat. Oncol. Biol. Phys., 2004, 58, 786.